Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00CLB
|
||||
Former ID |
DNC009267
|
||||
Drug Name |
SB-328872
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529558] | ||
Structure |
Download2D MOL |
||||
Formula |
C31H42N4O3S
|
||||
Canonical SMILES |
CC(C)CC(C(=O)NC1CCN(C1)CC2=CC=C(C=C2)OCCCN(C)C)NC(=O)C3<br />=CC4=CC=CC=C4S3
|
||||
InChI |
1S/C31H42N4O3S/c1-22(2)18-27(33-31(37)29-19-24-8-5-6-9-28(24)39-29)30(36)32-25-14-16-35(21-25)20-23-10-12-26(13-11-23)38-17-7-15-34(3)4/h5-6,8-13,19,22,25,27H,7,14-18,20-21H2,1-4H3,(H,32,36)(H,33,37)/t25-,27-/m0/s1
|
||||
InChIKey |
HLMWNBIZKQIDFC-BDYUSTAISA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Urotensin II receptor | Target Info | Inhibitor | [529558] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.